RICHMOND, Va., Sept. 19, 2016 /PRNewswire/ -- As part of its commitment to earlier-stage prevention and diagnosis of chronic diseases such as diabetes, cancer, autoimmune diseases and other healthcare concerns, True Health Diagnostics was pleased to provide proprietary testing services to researchers at Harvard Medical School studying the effect of omega-3 fatty acids on heart function in patients who have suffered a heart attack. Circulation, a publication of the American Heart Association, recently published their findings.
Logo - http://photos.prnewswire.com/prnh/20160916/408913LOGO
“True Health isn’t just a laboratory; it’s a center of discovery and innovation,” said Chief Medical Officer Dr. Kenneth Johnson. “The data points we collect drive scientific advancements. True Health is always working to develop new instrumentation and technology, as well as proprietary biomarkers and tests that can detect diseases earlier and speed treatment.”
True Health offers assays that enable early-stage diagnosis and monitoring for a spectrum of chronic disease states that help determine a patient’s risk for diabetes and rheumatoid arthritis, other autoimmune diseases, genetic diseases and various cancers, among others. Identifying potential disease as early as possible gives doctors more time to intervene and prescribe medications or lifestyle changes that may have a positive effect on a patient’s quality of life.
“Studies like the one initiated by Harvard Medical School are conducted to improve patient care. Their mission and ours are aligned. We were pleased that the Harvard Medical School team found our proprietary science valuable in the production of this report and hope that the results can help clinicians make stronger recommendations to patients on how to improve cardiac function,” said Chief Executive Officer Chris Grottenthaler.
The study on omega-3 fatty acids using the Omega-3 Index assay is available online at http://circ.ahajournals.org/content/134/5/378.
About True Health Diagnostics
True Health Diagnostics is a health services company, providing advanced clinical services and diagnostic information to help people live longer, healthier lives. The company specializes in earlier-stage prevention and diagnosis of chronic disease, including cardiovascular, diabetes, cancer, genetic disorders and a range of metabolic conditions. True Health is a trusted partner of medical professionals because we help them obtain accurate and necessary diagnoses that can improve patient care. True Health is headquartered in Frisco, Texas, with operations across the country. More information can be found at truehealthdiag.com.
Media Contact:
Lon Wagner
Vice President, Communications
(540) 556-2994
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/true-health-diagnostics-proprietary-testing-underpins-harvard-study-on-diet-cardiac-function-300329833.html
SOURCE True Health Diagnostics
